Intercytex (LSE: ICX), the cell therapy company developing products for the advanced woundcare and aesthetic medicine markets, today announces the appointment of Jan Benschop as Vice President, Commercial Development.
Intercytex (LSE: ICX), the cell therapy company developing products for the advanced woundcare and aesthetic medicine markets, today announces the appointment of Jan Benschop as Vice President, Commercial Development.